Eledon Pharmaceuticals (ELDN)
(Real Time Quote from BATS)
$3.46 USD
+0.33 (10.54%)
Updated Aug 6, 2025 03:10 PM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Eledon Pharmaceuticals, Inc. has a market cap of $187.43M, which represents its share price of $3.13 multiplied by its outstanding shares number of 59.88M. As a small-cap company, ELDN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ELDN 3.46 +0.33(10.54%)
Will ELDN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ELDN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELDN
Best Momentum Stocks to Buy for July 14th
New Strong Buy Stocks for July 14th
ELDN: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Makes Eledon Pharmaceuticals (ELDN) a New Buy Stock
Other News for ELDN
Catalyst Watch: Palantir earnings, Firefly Aerospace IPO, OPEC+, and the Fed's SLOOS report
Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase ...
12 Health Care Stocks Moving In Monday's After-Market Session
Eledon Pharmaceuticals (ELDN) Gains Positive Outlook Amidst New Developments | ELDN Stock News
Craig-Hallum bullish on Eledon Pharmaceuticals, initiates with a Buy